Carbon Reduction Statement 2024

                                               

Oswell Penda Pharmaceutical Ltd

Environmental Policy

General Statement

 

Oswell Penda Pharmaceutical Ltd is committed to protecting the environment, the health and safety of our employees and the community in which we conduct our business. We recognise that operating as a UK distributor and using contracted transport we have a significant part to play in reducing our impact on the environment. We are committed to minimising our environmental impact and promoting more sustainable practices. Our Environmental policy encompasses the following key principles:

 

  • We adopt climate-smart approaches to mitigate our impact on the environment in aid of achieving the 2050 climate neutrality target, we consider the most carbon-efficient routes for transport, additionally, we are assured these routes take place at off-peak times in modern aero-dynamic fuel-efficient vehicles that are regularly maintained and serviced.

 

  • At Oswell Penda Pharmaceutical Ltd the CEO Clare Judd and appointed Directors are committed to sustainable development by minimising waste, we partake in recycling packaging, paper, cardboard, scrap metal, and ink cartridges and invest in efficient use of energy and water.

 

  • We aim to accomplish continual improvement to reduce our impact on the environment by, participating in external auditing, certification, and carbon reduction development plans that we implement to the best of our ability, keeping sustainability in mind from resourcing to delivery.

 

  • At Oswell Penda Pharmaceutical Ltd we ensure the delivery partners we use meet the safety standard of ISO 14001 Environmental Management. This helps to improve environmental performance, through more efficient use of resources and a reduction of waste.

 

  • Oswell Penda Pharmaceutical are continuing to work towards improving the impact of the company Carbon footprint and plan to set out the company Carbon Reduction Plan in line with Government guidelines and legislation.

 

 

C Judd (CEO)

January 2024